Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) Invested Capital (2023 - 2025)

Bioharvest Sciences has reported Invested Capital over the past 3 years, most recently at $25.6 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 388.96% year-over-year to $25.6 million; the TTM value through Dec 2025 reached $25.6 million, up 388.96%, while the annual FY2025 figure was $25.6 million, 388.96% up from the prior year.
  • Invested Capital was $25.6 million for Q4 2025 at Bioharvest Sciences, up from -$876000.0 in the prior quarter.
  • Across five years, Invested Capital topped out at $25.6 million in Q4 2025 and bottomed at -$83.0 million in Q4 2023.
  • The 3-year median for Invested Capital is $2.7 million (2024), against an average of -$7.9 million.
  • The widest YoY moves for Invested Capital: up 388.96% in 2025, down 165.86% in 2025.
  • Over 3 years, Invested Capital stood at -$83.0 million in 2023, then skyrocketed by 106.31% to $5.2 million in 2024, then surged by 388.96% to $25.6 million in 2025.
  • The last three reported values for Invested Capital were $25.6 million (Q4 2025), -$876000.0 (Q1 2025), and $5.2 million (Q4 2024) per Business Quant data.